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BACKGROUND: The prevalence of metabolic syndrome (MS) has 
been continually increasing in developing countries especially in 
Thailand. Although insulin resistance and central obesity are 
initially considered as significant risk factors, the other causal 
factors leading to the development of MS continue to challenge the 
investigators. The aims of this study were to evaluate the 
prevalence of MS in Pathum Thani province, Thailand and to 
investigate the relationship between MS and risk factors.  
METHODS: This cross-sectional study was performed with 202 
Thai volunteers. Anthropometric-biochemical variables and blood 
pressures in each subject were measured.  
RESULTS: Almost one-third (32.7%) of the participants were 
diagnosed with MS based on the harmonized criteria, and one of 
the most significant risk factors is the elevated blood pressure. 
Weight, BMI, waist and hip circumferences, waist-hip ratio, blood 
pressure, glucose, triglycerides and uric acid were significantly 
higher in subjects with MS subjects. However, HDL-C levels were 
significantly lower in subjects with MS, compared to subjects 
without MS (p<0.001). The results of regression model after 
adjustment for age and gender showed that the increased serum 
uric acid level (OR=1.31, 95%CI: =1.04-1.66), cigarette smoking 
(OR=3.72, 95%CI: =1.51-9.15) and physical activity (OR=0.36, 
95%CI: =0.19-0.67) were significantly related to MS.  
CONCLUSIONS: These findings suggest that the decrease of uric 
acid level, the promotion of physical activity and smoking cessation 
may decrease the risk of developing MS among Thais.  




Metabolic syndrome (MS) is a public health problem that has 
reached epidemic proportions with a rapidly increasing worldwide 
prevalence and for the adult population is estimated to be about 20 to 
25% (1). There were evidences showing that MS is a clinical 
constellation comprising risk factors associated with increased risk of 
cardiovascular diseases (CVDs) by 2-fold and the risk of developing 
Type 2 diabetes by 5-fold (2, 3). Thus, the clustering symptoms 
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leading to Type 2 diabetes and CVDs are typified 
as the MS that is now considered to impact on 
global healthcare systems and financial plans. 
Thailand has gone through a period of epidemic 
transition, and many metabolic risk factors: 
obesity, dyslipidemia, insulin resistance, and 
hypertension, are now common among the Thai 
population (4). Obesity, especially visceral fat, 
remains an important link among the components 
of MS and the prevalence of obesity is rapidly 
growing in low- and middle-income countries 
including Thailand. The central region of Thailand 
has the highest prevalence of obesity for both 
males (38.8%) and females (49.4%), compared 
with other regions: the southern region (27.4% and 
44.7%), the northern region (27.5% and 36.3%) 
and the north-eastern region (22.5% and 39.1%) 
(5). Despite of the importance of MS in the context 
of noncommunicable diseases in Thailand, 
especially in the central region, information 
regarding the importance of the prevalence of MS 
and its determinants is scarce. The causal factors 
leading to the development MS continue to 
challenge the researchers. Therefore, this study 
aimed to evaluate the prevalence of MS in the 
population of Pathum Thani Province, the central 
region of Thailand and to investigate the 
relationship between MS and risk factors.  
 
MATERIALS AND METHODS  
 
Study subjects: The study was performed with 202 
Thai volunteers from the population in a suburban 
community located at the Lak-Hok in Pathum 
Thani Province, Thailand, aged between 20 to 80 
years old. This was a cross-sectional, population-
based study with simple random sampling between 
November 2017 and January 2019 with the 
objective to estimate the prevalence of MS and 
associated factors in the adult population. The 
subjects were invited to the Medical Technology 
Clinic of Rangsit University for laboratory 
examinations. All volunteers were interviewed by 
using a questionnaire, regarding lifestyle pattern, 
and medical health history. Participants who 
reported consuming alcohol at least once per week 
for more than 6 months were defined as drinkers. 
Participants who had smoked at least one cigarette 
per day for more than 6 months were defined as 
smokers. For Leisure-time physical activity, 
participants were asked whether they had engaged 
in regular exercise or sports (at least once a week 
for 3 months continuously). The exclusion criteria 
of this study included pregnancy, severe 
degenerative diseases, mental deficiency, stroke, 
cancer, kidney diseases, gout, and bedridden 
patients. MS was defined using the harmonized 
definition (6) and required at least three of the 
following:  
• Raised waist circumference: >90 cm in 
Asian men and >80 cm in Asian women 
• Raised blood pressure: systolic blood 
pressure >130 mmHg or diastolic blood 
pressure >85 mmHg, or current 
antihypertensive medication 
• Raised fasting plasma glucose: >100 
mg/dl 
• Raised triglycerides (TG) levels: >150 
mg/dl 
• Reduced high-density lipoprotein 
cholesterol (HDL-C): <40 mg/dl in men 
and <50 mg/dl in women 
This study was conducted under the principles of 
the Declaration of Helsinki and the protocol was 
approved by the Ethics Committee of Rangsit 
University (RSEC 11/2560). All participants 
agreeing to participate signed a consent form. 
Measurement of biochemical markers: Five 
milliliters of overnight fasting venous blood was 
taken from each subject. Serum was used to assay 
biochemical variables. For example, total 
cholesterol, triglycerides, HDL-cholesterol, LDL-
cholesterol, uric acid, total protein, and albumin. 
NaF blood was used to assay glucose, and these 
biochemical markers were measured by using 
COBAS INTEGRA® 400 plus analyzer, Roche 
Diagnostics Ltd., Switzerland.  
Anthropometric and blood pressure 
measurements: Anthropometric measurements 
comprising weight, height, waist circumferences, 
and hip circumference, were recorded. The body 
weight of each individual dressed in light clothing 
was measured using a carefully calibrated beam 
balance (Detecto®). The height of each individual 
was measured using a vertical-measuring rod. 
Waist circumference (WC) and hip circumference 
(HC) were calculated for waist-hip ratio (W/H 
ratio). The body mass index (BMI) was expressed 
as weight (kg) / height (m2). The participants were 
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classified according to their BMI as followings: 
normal weight (BMI<23.00 kg/m2), overweight 
(BMI≥23.00–24.99 kg/m2) and obese (BMI≥25.00 
kg/m2) (7). Blood pressure (BP) and pulse rate 
were measured by a nurse after 5 to 10 minutes’ 
rest in the sitting position. 
 
Statistical analysis: Statistics analyses were 
performed using SPSS for Windows version 17.0 
(SPSS, Chicago, IL). The median and 95% 
confidence interval (C.I.) were calculated. The 
difference between the two groups was compared 
by using the Mann-Whitney U-Wilcoxon Rank 
Sum W test. Relationship between MS and various 
parameters was tested using Chi-square test. The 
Minitab statistical computer program was used to 
calculate the odds ratio (OR). A p-value <0.05 was 




This cross-sectional study enrolled 202 participants 
with mean age 53.2 ± 3.2 years; 37.1% and 62.9% 
of all participants were males and females, 
respectively. Obesity and overweight rates in our 
study were 43.1% and 17.3%, respectively. 
Demographic and lifestyle characteristics of the 
studied population are shown in Table 1. More than 
thirty percent (32.7%) of the participants were 
diagnosed with MS based on the harmonized 
criteria, and the common risk factor was elevated 
blood pressure (Table 2).  
  
Table 1: Demographic, anthropometric and lifestyle characteristics of the studied population 
 
Characteristics  N (%) 




<12 years 119(58.9) 
> 12 years 83(41.1) 
BMI  Normal-weight 80(39.6) 
Overweight 35(17.3) 
Obese 87(43.1) 
Physical activity Inactive 75(37.1) 
Active 127(62.9) 
Cigarette smoking No 165(81.7) 
Yes 37(18.3) 
Alcohol consumption  No 154(76.2) 
Yes 48(23.8) 
 








Central obesity 111(55.0%) 
Elevated glucose 64(31.7%) 
Elevated TG 59(29.2%) 
Reduced HDL-C 52(25.7%) 
High blood pressure 120(59.4%) 
Metabolic syndrome 66(32.7%) 
 
HDL-C, high-density lipoprotein cholesterol 
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Anthropometric and biochemical data of the groups 
with MS (66 subjects) and without MS (136 
subjects) are shown in Table 3. Age, weight, BMI, 
WC, HC, waist-hip ratio, blood pressure, glucose, 
TG and uric acid were significantly higher in 
subjects with MS subjects than in that without MS 
(p<0.01). Meanwhile, HDL-C levels of subjects 
with MS were significantly lower than subjects 
without MS (p<0.01). The prevalence of MS 
according to age was showed that there was 
significantly different among age groups (p<0.05) 
and rising with aging years. The percentage of 
subjects with MS in each age group was: 20-39 
years (17.2%; 5/29), 40-49 years (25.0%; 8/32), 
50-59 years (31.7%; 26/82) and > 60 years (45.8%; 
27/59). Table 4 shows the risk factors are related to 
MS. Our results showed that lower secondary 
education (OR=1.99, p<0.05), cigarette smoking 
(OR=2.65, p<0.01), and physical activity 
(OR=0.37, p<0.01) were associated with MS. The 
proportions of cigarette smoking and physical 
activity between the MS group and the non-MS 
group were 28.8% vs 13.2%, 47.0% vs 70.6%, 
respectively. About 30.3% in the MS group and 
46.3% in the non-MS group had completed 
secondary level education or higher. The 
correlation of uric acid with components associated 
with metabolic syndrome is shown in Table 5. 
 
 





Subjects without MS 
(n=136) 




Mean (SD) Mean (SD) 
Age (years) 51.7(14.2) 56.2(10.4) 0.011* 
Weight (kg) 59.4(10.5) 68.2(11.4) <0.001** 
Height (cm) 159.4(8.2) 158.9(8.9) 0.669 
BMI (kg/m2) 23.3(3.4) 26.9(3.4) <0.001** 
WC (cm) 82.0(10.0) 93.2(7.3) <0.001** 
HC (cm) 95.4(7.1) 100.8(8.4) <0.001** 
Waist-hip ratio  0.86(0.07) 0.93(0.05) <0.001** 
Systolic BP (mmHg) 132.0(17.0) 142.0(18.0) <0.001** 
Diastolic BP (mmHg) 78.0(9.0) 82.0(11.0) 0.002** 
Pulse rate (beats/min) 78.0(10.0) 80.0(10.0) 0.147 
Glucose (mg/dl) 88.8(10.6) 116.8(17.2) <0.001** 
TC (mg/dl) 212.9(45.3) 208.8(44.9) 0.544 
TG (mg/dl) 110.3(39.0) 171.9 (30.0) <0.001** 
HDL-C (mg/dl) 63.4(15.1) 46.7(13.7) <0.001** 
LDL-C (mg/dl) 141.7(43.0) 137.7(41.9) 0.521 
Total protein (g/dl) 7.6(0.4) 7.7(0.4) 0.224 
Albumin (g/dl) 4.0(0.3) 4.0(0.2) 0.915 
Uric acid (mg/dl) 4.8(1.4) 5.4(1.4) 0.009** 
BMI, body mass index: WC, waist circumference: HC, hip circumference: BP, blood pressure: HDL-C, high-density 
lipoprotein cholesterol: LDL-C, low-density lipoprotein cholesterol: TG, triglyceride: TC, total cholesterol. 
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Table 4:  Risk factors related to MS 
 






Odds ratio  
(95% CI) 
p-value 
Gender Female 39(59.1%) 88(64.7%) 1.27 
(0.69-2.32) 
 0.439 
Male 27(40.9%) 48(35.3%)  
Education (schooling 
years) 
<12 years 46(69.7%) 73(53.7%) 1.99 
(1.06-3.70) 
0.030* 
> 12 years 20(30.3%) 63(46.3%)  
Physical activity Yes 31(47.0%) 96(70.6%) 0.37 
 (0.20-0.68) 
0.001** 
No 35(53.0%) 40(29.4%)  
Cigarette smoking Yes 19(28.8%) 18(13.2%) 2.65 
(1.28-5.49) 
0.007** 
No 47(71.2%) 118(86.8%)  
Alcohol consumption  Yes 14(21.2%) 34(25.0%) 0.81 
(0.40-1.64) 
0.553 
No 52(78.8%) 102(75.0%)  
*=p<0.05, **=p<0.01 by using Pearson chi-square, OR- Odds ratio: 95%CI, 95% confidence interval 
 
Serum uric acid level was positively correlated 
with BMI, WC, Waist-hip ratio, glucose and TG 
levels, but correlated negatively with HDL-C. The 
possible associations between MS and education, 
alcohol drinking, cigarette smoking, physical 
activity and uric acid, are shown in Table 6. The 
results of regression model after adjustment for age 
and gender showed that for every 1 mg/dl elevation 
in the serum uric acid level, the OR for developing 
MS had increased approximately 1.31-fold (95 
%CI: 1.04-1.66), and cigarette smoking was 3.72 
(95%CI: 1.51-9.15) times more likely to have MS. 
Meanwhile, physical activity was related to lower 
OR of the MS (OR= 0.36, 95% CI= 0.19-0.67).
 
Table 5: Correlation of uric acid with components associated with MS. (n=202) 
 
 
Parameters Correlation Coefficient p-value 
Glucose 0.161 0.020* 
TG 0.358 <0.001** 
HDL-C -0.397 <0.001** 
Systolic BP 0.028 0.749 
Diastolic BP 0.079 0.265 
BMI 0.316 <0.001** 
WC 0.357 <0.001** 
Waist-hip ratio 0.344 <0.001** 
 
*=p<0.05 by Spearman’s rank correlation (2-tailed) 
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Table 6: OR (95% CI) for predictors of MS, derived from logistic regression models with and without 
control for other factors (n=202) 
 




                  Education  
(<12 schooling years) 1.99* (1.06-3.70) 1.77(0.93-3.39) 
Alcohol consumption 0.81(0.40-1.64) 0.79 (0.37-1.67) 
Cigarette smoking   2.65**(1.28-5.49) 3.72**(1.51-9.15) 
Exercise activity  0.37** (0.20-0.68) 0.36** (0.19-0.67) 
Uric acid (mg/dl)  1.29*(1.06-1.59) 1.31* (1.04-1.66) 
 
OR-Odds ratio: 95%CI, 95% confidence interval, *=p<0.05, **=p<0.01 by using logistic regression. 




MS is the major health problem which is increasing 
worldwide. In the present study, the overall 
prevalence of MS among participants in a suburban 
community in Patumthani province was 32.7% 
based on the harmonized criteria. Our finding was 
concordant with the prevalence of MS in the 
InterASIA study among Thai adults from four 
regions of Thailand including the capital Bangkok 
(32.6%) (8) and Thai participants in Klong Luang, 
Pathum Thani Province (36.5%) (9). Its prevalence 
in Khon Kaen (15.0%), a northeast province of 
Thailand, was lower than the our study (10). 
Moreover, the prevalence of MS in this finding is 
in line with the countries of the Asia-Pacific region 
ranged from 11% to 40% (11), such as 27.9% in 
Malaysia (12) and 33% in India (13). However, the 
difference in the prevalence may be due to the 
differences in the race and MS definition, 
especially in the cut-off points of waist 
circumference and fasting glucose level. 
 Additionally, the difference in participants’ 
lifestyle may contribute to distinct prevalence 
levels; Pathum Thani Province, a neighboring 
province of the capital city of Thailand, has gone 
through a period of epidemic transition, and risk 
factors associated with MS such as obesity plus a 
sedentary lifestyle are commonly found in this 
population (9). Furthermore, this study found that 
the prevalence of MS was age-dependent with the 
highest prevalence in participants with age of >60 
years old. This finding was in accordance with 
other studies (14,15) because many predisposing 
conditions which rising in the MS prevalence 
during aging, such as insulin resistance, obesity 
and hypertension (15). Hypertension was the major 
component of MS in our study followed by central 
obesity, and this finding was similar to a 
comprehensive review of Katsimardou et al. that 
hypertension was present in almost 80% of patients 
with MS (16). Regarding hypertension in MS, the 
pathophysiologic mechanism had been proposed 
that insulin resistance can stimulate the 
sympathetic nervous system and decrease nitric 
oxide production, contributing to increases in blood 
pressure (17,18). Hypertension is the most common 
modifiable risk factor for cardiovascular disease 
(CVD) including coronary heart disease, 
myocardial infarction, heart failure, and stroke 
(19). Therefore, MS patients have a higher 
susceptibility for cardiovascular problems.  
The underlying cause of MS is visceral 
obesity, and adipose tissue is a major organ that has 
plentiful activity of xanthine oxidoreductase 
(XOR) and the role of adipose tissue per se in the 
production of uric acid with a special focus on 
XOR, an enzyme known to catalyze purines, such 
as xanthine and hypoxanthine, to uric acid (20,21). 
The explanation of this relation may be associated 
with hypoxia of obese adipose tissue that hypoxic-
induced increase in XOR activity has been revealed 
in several studies (20,22,23), and hypoxia also 
induces dysfunction of adipose tissue, such as 
dysregulation of adipocytokines. In agreement with 
Tsushima et al. (20), our data found positive 
correlation of uric acid levels with obesity indices 
including WC and BMI. A study in identical twins 
also reported that serum uric acid was found to be 
significantly correlated with BMI even after 
adjusting for genetic and family environment 
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factors (24). Moreover, the present study revealed 
the association between serum uric acid and TG; 
this relation is in line with previous studies (25,27). 
There are some potential mechanisms for this 
relationship that TG synthesis accelerates the de 
novo synthesis of ribose-5-phosphate to 
phosphoribosyl pyrophosphate (PPRP) through the 
common metabolic pathway of NADP-NADPH, 
and as a result of increasing uric acid production 
(28). Our results also showed that serum uric is 
correlated with glucose, and this finding has been 
reported in some previous studies (27,29). The 
potential mechanism is that increased uric acid 
levels can block the activation of AMPK, leading 
to the translocation of the transducer of regulated 
CREB activity 2 (TORC2) to the nucleus and the 
transcription of phosphoenolpyruvate 
carboxykinase (PEPCK) and glucose-6-
phosphatase (G6Pc) that stimulate de novo 
production of glucose (30). Therefore, our data 
provided confirmation of findings on association 
between serum uric acid and components of MS. 
The result of logistic regression analyses 
showed that after adjusted with age and sex, 
cigarette smoking and hyperuricemia were risk 
factor whereas physical activity was a protective 
factor of MS. Our study revealed that the person 
with high serum uric acid had 1.31 times higher in 
the odd of MS development, and this was 
consistent with the studies in Taiwan (31) and Iran 
(32). However, the precise biological mechanisms 
underlying the relationship between serum uric 
acid and developing MS remain unclear. Zhu et al. 
found that increased uric acid level may directly 
inhibit insulin receptor substrate-1 (IRS-1) and Akt 
insulin signaling and induce insulin resistance, 
which is the key pathophysiology of MS (33). 
Although TG synthesis stimulates the uric acid 
production, Kuwabara et al. (34) found that 
hyperuricemia is the risk factor for developing 
hypertriglyceridemia. Oxidative stress may be 
responsible for uric acid mediated-
hypertriglyceridemia via citrate accumulation and 
stimulation of ATP citrate lyase leading to 
increased fat production (35). Additionally, our 
study revealed that hypertension is the major 
component of MS, and the study of Loeffler et al. 
found that hyperuricemia is the risk factor of 
hypertension (36). The mechanism for uric acid 
mediated hypertension could be described by the 
induction of endothelial dysfunction (37) and 
activation of the renin-angiotensin system (38). 
Therefore, it has been suggested that serum uric 
acid might be an additional component of MS.  
Our study has shown that low education level 
was prone to MS occurrence; similar data were 
reported by Kim et al. (39). A study done by 
Silventoinen et al. (40) also found that the 
prevalence of MS was less in university education 
level. These data may partly explain by the impact 
of education that has the potential to improve the 
dietary habits and lifestyle while reducing 
incidences of MS (39,41). Moreover, the result of 
the present study is consistent with results from a 
meta-analysis of Sun et al. that cigarette smoking is 
associated with developing MS (42). Bergman et 
al. indicated that nicotine exposure had 
significantly increased IRS-1ser636 phosphorylation 
and decreased insulin sensitivity (43). Serine 
phosphorylation of many sites on (IRS-1), 
including ser636 decreases IRS-1 tyrosine 
phosphorylation and insulin-stimulated glucose 
uptake (44). These data suggest that inhibition of 
insulin signaling may be an important mechanism 
responsible for cigarette smoking-induced insulin 
resistance, and many features of the MS are related 
to insulin resistance. Furthermore, smoking can 
increase blood pressure, waist circumference, 
triglycerides, and reduce HDL-C (42). In the 
present study, we found that leisure-time physical 
activity was a protective factor for reducing MS in 
Thais. This result was consistent with a meta-
analysis of Roomi et al. (41) and in Taiwanese 
workers (45). Huang et al. revealed that a high 
level of physical activity had lower risks of MS 
including abdominal adiposity and 
hypertriglyceridemia (45). The underlying 
mechanisms for the advantages of high-intensity 
exercise may involve in improved lipid biogenesis 
in the adipose tissues and liver (46) and in 
increased HDL-C by stimulating expression of 
post-heparin lipoprotein lipase (47). Hence, the MS 
may be prevented by changing the lifestyle to 
lower the risk factor including frequent exercise 
and smoking cessation. This information derived 
from Thais should be more applicable to our 
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society and other countries to improve the quality 
of life and reduce the risk of various 
noncommunicable diseases related to MS. 
The limitations of our study are the small 
sample size of both groups and the lack of diabetes 
indices including insulin and HOMA-IR value for 
evaluation of insulin resistance. Therefore, further 
studies are required on larger cohorts with different 
ethnic groups.  
In summary, the overall prevalence of MS in a 
suburban community in Pathum Thani Province, 
Thailand, was 32.7%; hypertension was the major 
component of MS. The increased serum uric acid 
level, cigarette smoking and lack of physical 
activity were significantly associated with 
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